Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Ralph Edwards

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
The International Journal of Risk & Safety in Medicine|March 17, 2020
Risk and safety: What's the point?I Ralph Edwards, Marie Lindquist
Drug Safety|January 22, 2014
Pharmacovigilance for children's sakeKristina Star, I Ralph Edwards
BMC Neurology|October 18, 2015
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapsesOla Caster, I Ralph Edwards
The International Journal of Risk & Safety in Medicine|August 2, 2021
What is fake news in science?I Ralph Edwards, Marie Lindquist
Expert Opinion on Drug Safety|June 16, 2006
The challenge of effectively communicating patient safety informationBruce Hugman, I Ralph Edwards
The International Journal of Risk & Safety in Medicine|January 18, 2021
New year, new hopeI Ralph Edwards, Marie Lindquist
The International Journal of Risk & Safety in Medicine|March 23, 2012
Forensic pharmacovigilanceI Ralph Edwards, David Body
Drug Safety|September 4, 2010
Reflections on attribution and decisions in pharmacovigilanceOla Caster, I Ralph Edwards
Drug Safety|July 20, 2010
What do stakeholders think about pharmacovigilance?I Ralph Edwards, Teresa Graedon
The International Journal of Risk & Safety in Medicine|May 3, 2021
What is 'risk and safety in medicine'?I Ralph Edwards, Marie Lindquist
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
The International Journal of Risk & Safety in Medicine|March 17, 2020
Risk and safety: What's the point?I Ralph Edwards, Marie Lindquist
Drug Safety|January 22, 2014
Pharmacovigilance for children's sakeKristina Star, I Ralph Edwards
BMC Neurology|October 18, 2015
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapsesOla Caster, I Ralph Edwards
The International Journal of Risk & Safety in Medicine|August 2, 2021
What is fake news in science?I Ralph Edwards, Marie Lindquist
Expert Opinion on Drug Safety|June 16, 2006
The challenge of effectively communicating patient safety informationBruce Hugman, I Ralph Edwards
The International Journal of Risk & Safety in Medicine|January 18, 2021
New year, new hopeI Ralph Edwards, Marie Lindquist
The International Journal of Risk & Safety in Medicine|March 23, 2012
Forensic pharmacovigilanceI Ralph Edwards, David Body
Drug Safety|September 4, 2010
Reflections on attribution and decisions in pharmacovigilanceOla Caster, I Ralph Edwards
Drug Safety|July 20, 2010
What do stakeholders think about pharmacovigilance?I Ralph Edwards, Teresa Graedon
The International Journal of Risk & Safety in Medicine|May 3, 2021
What is 'risk and safety in medicine'?I Ralph Edwards, Marie Lindquist
Pageof 10